[Experience in the surgical treatment of 748 patients with lung cancer].

作者
Wang Lj,Huang Gj,Zhang Dw,Zhang Rg,Xu Pz,Ling Peng,Jianxing He
出处
期刊:PubMed [National Institutes of Health]
卷期号:8 (4): 283-6 被引量:3
链接
标识
摘要

A series of 748 patients with lung cancer as treated by surgery from 1961 to 1984 is reported. Regular lobectomy was done in 445 (74%) patients, bronchoplastic lobectomy in 67 (11.2%), segmental or wedge excision in 15 (2.5%) and pneumonectomy in 74 (12.3%) in which the ratio of left to right pneumonectomy was 2.9:1. Overall resection rate was 80.4% (601/748) and resection mortality was 1.2% (7/601) (death within 30 days of operation). Overall 5 year survival rate was 42% (169/402). The 5 year survival rate was 35.3% for pneumonectomy, 54.1% for bronchoplastic lobectomy, 42.3% for regular lobectomy and 16.7% for segmental or wedge excision. In this analysis, emphasis is laid to the therapeutic validity of the different modes of surgery. Statistical data show that only when the indication of different surgical interventions are strictly adhered to and the reasonable procedures are carried out, could better results be obtained. In surgical treatment of lung cancer, it is an important principle to eradicate the tumor and its metastatic foci as thorough as possible and to conserve the respiratory function as much as possible. Regular lobectomy has now become the "standard" and first choice operation. Pneumonectomy should be reserved for the patients with absolute necessity due to the extent of the lesion, adequate cardiopulmonary function and possibility of a permanent cure. Pneumonectomy is substituted by bronchoplastic lobectomy to a certain degree, preserving more of the lung function and improving the living quality after operation and long term results. Extensive practice of this surgical modality is advised.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
生物摸鱼大师完成签到,获得积分10
3秒前
4秒前
5秒前
5秒前
爆米花应助活力数据线采纳,获得10
5秒前
爱学习完成签到,获得积分10
5秒前
科研通AI6.4应助OTW采纳,获得10
5秒前
Sandwich完成签到,获得积分10
5秒前
天天快乐应助小池同学采纳,获得10
7秒前
leeap完成签到 ,获得积分10
7秒前
乔治的恐龙完成签到 ,获得积分10
8秒前
果果完成签到 ,获得积分10
9秒前
kuaileYF完成签到,获得积分10
9秒前
赘婿应助活泼的澜采纳,获得10
11秒前
libaokuu发布了新的文献求助50
11秒前
小小鸟发布了新的文献求助10
11秒前
654-2发布了新的文献求助10
11秒前
12秒前
西瓜瓜完成签到,获得积分10
13秒前
kuaileYF发布了新的文献求助10
14秒前
甜玉米发布了新的文献求助10
14秒前
15秒前
赘婿应助眠羊采纳,获得20
17秒前
whereisit发布了新的文献求助10
17秒前
友好沛槐完成签到,获得积分10
19秒前
19秒前
研友_VZG7GZ应助tang采纳,获得10
20秒前
情怀应助良橼采纳,获得10
21秒前
21秒前
路灯下的小伙完成签到,获得积分10
23秒前
whereisit完成签到,获得积分10
23秒前
24秒前
24秒前
活泼的澜发布了新的文献求助10
25秒前
豫安发布了新的文献求助10
26秒前
26秒前
26秒前
27秒前
27秒前
GUO发布了新的文献求助10
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Reducing Compassion Fatigue, Secondary Traumatic Stress and Burnout 600
Comparative Elite Sport Development Systems, Structures and Public Policy 600
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Auslegungsgeschichte 500
Cosmos as Art Object: Studies in Plato's Timaeus and Other Dialogues 500
What is the Future of Psychotherapy in Digital Age? Technology, AI Bots, and Psychotherapy after Covid 444
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7637702
求助须知:如何正确求助?哪些是违规求助? 9211219
关于积分的说明 19758251
捐赠科研通 7204883
什么是DOI,文献DOI怎么找? 3275753
关于科研通互助平台的介绍 2437346
邀请新用户注册赠送积分活动 2272922